Segment Information

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Segment Information

Segment Information

The following table summarizes select operating results for each reportable segment (in millions).

	Three Months Ended
	March 31,
	2023		2022
Revenues
Medical	$	66.4	$	60.1
Industrial	115.7		103.1
Consolidated Revenues	$	182.1	$	163.2
Segment Income (Loss) from Operations
Medical	$	0.7	$	(6.7)
Industrial	5.5		(2.5)
Total Segment Income (Loss) from Operations	6.2		(9.2)
Corporate and other	(19.8)		(24.4)
Consolidated Loss from Operations	$	(13.6)	$	(33.6)

Beginning January 1, 2023, the Company began measuring segment performance to include the impact of expenses identified as non-operating. Previously, these expenses would have been included with Corporate and other. Segment income (loss) from operations for the three months ended March 31, 2022 has been adjusted for comparability.

The Company’s assets by reportable segment were not included, as this information is not reviewed by, nor otherwise provided to, the chief operating decision maker to make operating decisions or allocate resources.

The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).

	Revenues
	Three Months Ended
	March 31,
	2023		2022
North America
Medical	$	60.7	$	55.6
Industrial	55.2		42.2
Total North America	115.9		97.8
Europe
Medical	5.7		4.5
Industrial	53.1		53.2
Total Europe	58.8		57.7
Asia Pacific
Medical	—		—
Industrial	7.4		7.7
Total Asia Pacific	7.4		7.7
Total revenues	$	182.1	$	163.2

The following details revenues by timing of recognition (in millions):

	Revenues
	Three Months Ended
	March 31,
	2023		2022
Point in time	$	118.3	$	117.0
Over time	63.8		46.2
Total revenues	$	182.1	$	163.2

The following details revenues by product category (in millions):

	Revenues
	Three Months Ended
	March 31,
	2023		2022
Medical segment:
Medical	$	66.4	$	60.1
Industrial segment:
Reactor Safety and Control Systems	42.1		30.8
Radiological Search, Measurement, and Analysis Systems	73.6		72.3
Total revenues	$	182.1	$	163.2